Delivery Order SPE2DB22D1103-SPE2DB24FTGY7
Award Date 3/22/24
Potential Completion Date 3/25/24
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,352.76 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TWINRIX VACCINE SYRINGEML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract (SPE2DB20D2002|SPE2DB24FL31A) worth $1,779.70 to provide the TWINRIX VACCINE SYRINGEML product. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded a $1,008.53 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGE ML product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a prime contractor and for-profit organization, to provide the TWINRIX VACCINE SYRINGE ML product. The $9,131.33 delivery order has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation and serves as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of TWINRIX vaccine syringes. The contract, valued at $1,846.48, has a completion date of July 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $231,266.24 firm fixed price delivery order contract to provide TWINRIX VACCINE SYRINGEML. This order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $6,403.66 firm fixed-price delivery order contract for TWINRIX VACCINE SYRINGEML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of medical commodities, including pharmaceutical products, to support military treatment programs and facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGE ML pharmaceutical product. The $1,352.76 contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award and has received numerous prior contracts from DLA to supply pharmaceuticals and medical supplies in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,107,101 units of the TWINRIX vaccine in syringes. The $3,298.23 contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 2025 to deliver pharmaceuticals and...
- The Defense Logistics Agency has awarded a firm fixed price delivery order contract valued at $2,008.92 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Twinrix vaccine syringes. The contract has a completion date of February 26, 2024 and was awarded on February 23, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTGY7Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGEML product. The contract, valued at $1,408.95, has an ultimate completion date of March 25, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and medical supplies in support of military treatment programs and facilities worldwide. The contract has no set-aside designation.
Generated 6/21/24, 10:02 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 3/22/24 |